Intervacc is trading at €0.04, with a -23.16% change; no confirmed company-specific announcement explains the October 23, 2026 decline.
- The company’s investor page lists an EMA application for longer Strangvac immunity, but does not link it to the move.
- Supplied market context reports October 22 declines in major U.S. indices amid AI-spending and geopolitical concerns; evidence does not establish these events directly caused Intervacc’s fall.